 |
 |

Routine Screening for Lung Cancer?
Maybe Someday, but Not Yet
Paul S. Frame, MD
JAMA. 2000;284:1980-1983.
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
 |
 |
Lung cancer is the leading cause of cancer death worldwide and accounts for 28% of all cancer deaths in the United States.1 It is largely a preventable disease. In the United States, more than 90% of lung cancer cases are related to cigarette smoking. Treatment of lung cancer is not very effective and has changed little in the past 40 years. Surgical resection of localized tumors is the only potentially curative treatment, and many tumors are not resectable at the time of diagnosis. Overall current 5-year survival rates are 8% to 14% for whites and 5% to 11% for blacks.2
In view of the large burden of suffering and the poor prognosis for persons with the disease, it is not surprising that screening for the early detection of lung cancer at a curable stage has been a research priority for many years. Indeed, 8 prospective studies . . . [Full Text of this Article] Historical Perspective
Author Affiliations: Tri-County Family Medicine, Cohocton, NY, and University of Rochester School of Medicine and Dentistry, Rochester, NY.
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
RELATED ARTICLE
Screening Strategies for Early Detection of Lung Cancer: The Time Is Now
Thomas L. Petty
JAMA. 2000;284(15):1977-1980.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
 |
Enthusiasm for Cancer Screening in the United States
Schwartz et al.
JAMA 2004;291:71-78.
ABSTRACT
| FULL TEXT
Liability of Performing CT Screening for Coronary Artery Disease and Lung Cancer
Berlin
Am. J. Roentgenol. 2002;179:837-842.
FULL TEXT
Lung Cancer Screening, Once Again
Marcus
Chest 2002;122:3-4.
FULL TEXT
Improved Survival and Higher Mortality* : The Conundrum of Lung Cancer Screening
Reich
Chest 2002;122:329-337.
FULL TEXT
The Mayo Lung Cohort: A Regression Analysis Focusing on Lung Cancer Incidence and Mortality
Strauss
JCO 2002;20:1973-1983.
ABSTRACT
| FULL TEXT
The 21st Century: The Age of Screening
Friedenberg
Radiology 2002;223:1-4.
FULL TEXT
Marketing Medicine to the Public: A Reader's Guide
Schwartz and Woloshin
JAMA 2002;287:774-775.
FULL TEXT
Dot Size, Lead Time, Fallibility, and Impact on Survival: Continuing Controversies in Mammography
Berlin
Am. J. Roentgenol. 2001;176:1123-1130.
FULL TEXT
Lung Cancer Screening
Granat et al.
JAMA 2001;285:163-164.
FULL TEXT
|